Table 1.

Demographic features, laboratory parameters, treatments, and outcomes of patients with iTTP (n = 97)

ParametersValues*
Age, y (n = 97) 45 (34-52.5) 
Sex (n = 83)  
 Female 47 (56.6) 
 Male 36 (43.4) 
Race (n = 83)  
 African American 68 (81.9) 
 White 15 (18.1) 
Disease status (n = 97)  
 Initial 60 (61.9) 
 Relapse 37 (38.1) 
Blood group (n = 83)  
 O 45 (54.2) 
 Non-O 38 (45.8) 
BMI 33.6 (29.0-41.0) 
Comorbidities  
 Hypertension (n = 97) 48 (49.5) 
 Diabetes mellitus (n = 97) 22 (22.7) 
 SLE (n = 44) 8 (18.2) 
 HIV (n = 67) 6 (9.0) 
Symptoms (n = 97)  
 CNS symptoms 52 (53.6) 
 Fever 16 (16.5) 
 Chest pain 13 (13.4) 
 Abdominal pain 25 (25.8) 
ParametersValues*
Age, y (n = 97) 45 (34-52.5) 
Sex (n = 83)  
 Female 47 (56.6) 
 Male 36 (43.4) 
Race (n = 83)  
 African American 68 (81.9) 
 White 15 (18.1) 
Disease status (n = 97)  
 Initial 60 (61.9) 
 Relapse 37 (38.1) 
Blood group (n = 83)  
 O 45 (54.2) 
 Non-O 38 (45.8) 
BMI 33.6 (29.0-41.0) 
Comorbidities  
 Hypertension (n = 97) 48 (49.5) 
 Diabetes mellitus (n = 97) 22 (22.7) 
 SLE (n = 44) 8 (18.2) 
 HIV (n = 67) 6 (9.0) 
Symptoms (n = 97)  
 CNS symptoms 52 (53.6) 
 Fever 16 (16.5) 
 Chest pain 13 (13.4) 
 Abdominal pain 25 (25.8) 

CNS, central nervous system; O, blood type O; SLE, systemic lupus erythematosus.

*

Age and BMI are expressed as the median (IQR). All other parameters are expressed as n (%) of patients.

or Create an Account

Close Modal
Close Modal